gvtcx

CF - Complete Ophthalmology Solutions 3

Supply Chain Coordination Limited Published 16 Oct 2024 Contracts Finder

key details

Value£360,000,000
Statuscomplete
Category (CPV) 33662100 +9 more
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline25 Nov 2024
Contract start3 Nov 2025
Contract end2 Nov 2027
Procedureopen
SME suitableYes
OCIDocds-b5fd17-a02ac208-89fb-4485-964c-eee06128ea7e

Awards (53)

This procurement was awarded to 53 suppliers. Values shown are per-award; the notice total is £360,000,000.

SupplierValueDateStatus
201 Silbury Boulevard, Milton Keynes, Buckinghamshire, MK9 1LZ shared £360,000,000 2 Sept 2025 active
Accrington Surgical Instrument Suppliers Limited shared £360,000,000 2 Sept 2025 active
Albert Waeschle Limited shared £360,000,000 2 Sept 2025 active
Alcon Eye Care UK Limited shared £360,000,000 2 Sept 2025 active
Altomed Limited shared £360,000,000 2 Sept 2025 active
AMO United Kingdom Limited shared £360,000,000 2 Sept 2025 active
Andersen Caledonia Limited shared £360,000,000 2 Sept 2025 active
Associated Optical Products shared £360,000,000 2 Sept 2025 active
Bausch & Lomb U.K. Limited shared £360,000,000 2 Sept 2025 active
Beaver-Visitec International Sales Limited shared £360,000,000 2 Sept 2025 active
Birmingham Optical Group Limited shared £360,000,000 2 Sept 2025 active
Blink Medical Limited shared £360,000,000 2 Sept 2025 active
Carl Zeiss Ltd shared £360,000,000 2 Sept 2025 active
Clonallon Laboratories Ltd shared £360,000,000 2 Sept 2025 active
Core Surgical Limited shared £360,000,000 2 Sept 2025 active
Daybreak Medical Limited shared £360,000,000 2 Sept 2025 active
D.O.R.C. Limited shared £360,000,000 2 Sept 2025 active
DTR Medical Limited shared £360,000,000 2 Sept 2025 active
Duckworth And Kent Limited shared £360,000,000 2 Sept 2025 active
Ezidrops Ltd shared £360,000,000 2 Sept 2025 active
Glaukos Uk Limited shared £360,000,000 2 Sept 2025 active
Grafton Optical Company Limited shared £360,000,000 2 Sept 2025 active
Hanson Instruments Limited shared £360,000,000 2 Sept 2025 active
Heidelberg Engineering Limited shared £360,000,000 2 Sept 2025 active
Innovant Healthcare Limited shared £360,000,000 2 Sept 2025 active
Joint Operations Ltd shared £360,000,000 2 Sept 2025 active
KCI Medical Limited shared £360,000,000 2 Sept 2025 active
Leica Microsystems (UK) Limited shared £360,000,000 2 Sept 2025 active
Lenstec (Barbados) Inc shared £360,000,000 2 Sept 2025 active
Litechnica Limited shared £360,000,000 2 Sept 2025 active
Main Line (Instruments) Limited shared £360,000,000 2 Sept 2025 active
Medscience Distribution Ltd shared £360,000,000 2 Sept 2025 active
Meticuly Innovations Ltd shared £360,000,000 2 Sept 2025 active
Molnlycke Health Care Limited shared £360,000,000 2 Sept 2025 active
Optelec Limited shared £360,000,000 2 Sept 2025 active
Optos Public Limited Company shared £360,000,000 2 Sept 2025 active
Oscartech UK Ltd shared £360,000,000 2 Sept 2025 active
Osi Inc. Ltd shared £360,000,000 2 Sept 2025 active
Rayner Intraocular Lenses Limited shared £360,000,000 2 Sept 2025 active
RB Medical Engineering Limited shared £360,000,000 2 Sept 2025 active
Rudolf Riester Gmbh shared £360,000,000 2 Sept 2025 active
Scope Ophthalmics Limited shared £360,000,000 2 Sept 2025 active
Sense Medical Limited shared £360,000,000 2 Sept 2025 active
Sight Sciences Inc shared £360,000,000 2 Sept 2025 active
Soluvos Medical Ltd shared £360,000,000 2 Sept 2025 active
Surgitrac Instruments UK Limited shared £360,000,000 2 Sept 2025 active
Topcon Great Britain Medical, Branch Of Topcon Europe Medical B. shared £360,000,000 2 Sept 2025 active
Uniphar Medtech T/A M.E.D. Surgical shared £360,000,000 2 Sept 2025 active
Unisurge International Limited shared £360,000,000 2 Sept 2025 active
Veni Vidi Medical Limited shared £360,000,000 2 Sept 2025 active
Vernacare International Limited shared £360,000,000 2 Sept 2025 active
Vision Matrix Limited shared £360,000,000 2 Sept 2025 active
Vision Pharmaceuticals Ltd shared £360,000,000 2 Sept 2025 active

description

The purpose of this framework is to offer the NHS an all-encompassing Ophthalmology solution with all products available under one framework agreement to enable the NHS to get the most economical and advantageous route to market with an avenue to realise maximum potential on savings.

It is anticipated that initial expenditure for this Framework will be circa £90,000,00 GBP in the first year of this Framework Agreement. If the Framework Agreement is extended to the maximum duration, the anticipated expenditure will be circa £360,000,000 GBP. These are approximates only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

This framework agreement will have an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
14 Mar 2024 Planning (planning) · 554230d0-fc5d-4741-a29d-213598811075-732043
16 Oct 2024 Tender (tender) · ce97d970-87eb-46c2-9d56-34ee511e0b82-794447
2 Oct 2025 Award (award) · 61748847-db27-4952-a35e-9c83190792c3-866512

more from Supply Chain Coordination Limited

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.